QT Imaging (QTI) Competitors $2.55 +0.15 (+6.25%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock QTI vs. CATX, TLSI, OM, SI, MGRM, NNOX, INGN, STIM, ELMD, and INFUShould you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include Perspective Therapeutics (CATX), TriSalus Life Sciences (TLSI), Outset Medical (OM), Shoulder Innovations (SI), Monogram Orthopaedics (MGRM), Nano-X Imaging (NNOX), Inogen (INGN), Neuronetics (STIM), Electromed (ELMD), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry. QT Imaging vs. Its Competitors Perspective Therapeutics TriSalus Life Sciences Outset Medical Shoulder Innovations Monogram Orthopaedics Nano-X Imaging Inogen Neuronetics Electromed InfuSystem QT Imaging (NASDAQ:QTI) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability. Do analysts recommend QTI or CATX? Perspective Therapeutics has a consensus target price of $12.56, indicating a potential upside of 249.74%. Given Perspective Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Perspective Therapeutics is more favorable than QT Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score QT Imaging 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Perspective Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 3 Strong Buy rating(s) 3.18 Do institutionals and insiders believe in QTI or CATX? 24.2% of QT Imaging shares are held by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are held by institutional investors. 75.4% of QT Imaging shares are held by insiders. Comparatively, 3.7% of Perspective Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, QTI or CATX? QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Is QTI or CATX more profitable? QT Imaging has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. QT Imaging's return on equity of 0.00% beat Perspective Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets QT ImagingN/A N/A -65.94% Perspective Therapeutics -4,096.66%-27.40%-23.16% Which has higher earnings and valuation, QTI or CATX? QT Imaging has higher revenue and earnings than Perspective Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQT Imaging$4.00M17.31-$4.03MN/AN/APerspective TherapeuticsN/AN/A-$46.51MN/AN/A Does the media refer more to QTI or CATX? In the previous week, Perspective Therapeutics had 3 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Perspective Therapeutics and 0 mentions for QT Imaging. Perspective Therapeutics' average media sentiment score of 1.76 beat QT Imaging's score of 0.00 indicating that Perspective Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment QT Imaging Neutral Perspective Therapeutics Very Positive SummaryPerspective Therapeutics beats QT Imaging on 9 of the 14 factors compared between the two stocks. Get QT Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QTI vs. The Competition Export to ExcelMetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$69.19M$44.62M$5.79B$10.18BDividend YieldN/AN/A5.73%4.61%P/E RatioN/A4.1374.8626.40Price / Sales17.31221.20543.29125.95Price / CashN/A41.3625.8129.91Price / Book-1.342.5313.256.28Net Income-$4.03M-$2.66M$3.29B$270.38M7 Day Performance2.82%-0.62%0.47%2.70%1 Month Performance27.50%14.22%4.60%5.99%1 Year Performance388.04%226.40%73.42%25.94% QT Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QTIQT ImagingN/A$2.55+6.3%N/A+388.0%$69.19M$4.00M0.00N/ACATXPerspective Therapeutics2.1354 of 5 stars$3.37-1.7%$12.56+272.6%-77.0%$250.27MN/A0.0070Positive NewsTLSITriSalus Life Sciences3.0973 of 5 stars$4.90-2.2%$10.75+119.4%-2.0%$249.84M$29.43M-4.15106OMOutset Medical2.1252 of 5 stars$14.19+2.8%$24.67+73.8%+72.2%$245.35M$113.69M-0.70520SIShoulder Innovations3.3186 of 5 stars$14.87-6.5%$19.60+31.8%N/A$242.13MN/A-0.5061News CoverageAnalyst UpgradeHigh Trading VolumeMGRMMonogram Orthopaedics1.7724 of 5 stars$5.77+0.3%$5.40-6.4%+75.3%$233.64M$370K-11.5428Short Interest ↓NNOXNano-X Imaging2.9601 of 5 stars$3.99-0.7%$8.50+113.0%-38.3%$232.27M$11.28M-4.43190INGNInogen4.0987 of 5 stars$8.53+0.9%$11.00+29.0%-24.6%$228.49M$335.70M-8.051,030Positive NewsSTIMNeuronetics2.0262 of 5 stars$3.69+9.5%$7.00+89.7%+328.2%$222.84M$111.11M-3.27180Positive NewsELMDElectromed3.993 of 5 stars$26.61+6.6%$36.25+36.2%+31.0%$222.17M$64M35.48160News CoverageInsider TradeINFUInfuSystem3.1113 of 5 stars$10.42+1.6%$12.50+20.0%+53.5%$212.84M$139.89M173.70410Positive News Related Companies and Tools Related Companies CATX Competitors TLSI Competitors OM Competitors SI Competitors MGRM Competitors NNOX Competitors INGN Competitors STIM Competitors ELMD Competitors INFU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QTI) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QT Imaging Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share QT Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.